The Lancet Diabetes & Endocrinology in conversation with
The Lancet Diabetes & Endocrinology in conversation with
The Lancet Group
Hertzel Gerstein on dulaglutide, erectile dysfunction, and T2D
24 minutes Posted Jul 9, 2021 at 12:00 pm.
0:00
24:00
Download MP3
Show notes

Hertzel Gerstein talks with The Lancet Diabetes & Endocrinology about how dulaglutide might reduce the incidence of moderate or severe erectile dysfunction in men with type 2 diabetes.